Switch iconSwitch
Homepage iconHomepage facebook iconfacebook IG iconIG Hospital iconOther Hospital CMUH APP iconCMUH App
About CMUH

News and Award

:::
Home/
About CMUH/
News and Award/
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

About CMUH

2025/2/17

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial

Authors: Paul Glue, Colleen Loo, Johnson Fam, Hsien-Yuan Lane, Allan H. Young, Peter Surman, BEDROC study investigators

Journal: NATURE MEDICINE

Publication Date: 2024

Image Source: NATURE MEDICINE

Link: https://pubmed.ncbi.nlm.nih.gov/38914860/

回上頁

Related Articles

Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers img
Diagnosing Alzheimer's Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research img
Targeting D-Amino Acid Oxidase (DAAO) for the Treatment of Schizophrenia: Rationale and Current Status of Research
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial img
Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial
Stay connected with CMUH
facebook Facebook
IG
youtube YouTube
How to get to CMUH the map of hospital
Download
▲